The Nasdaq Stock Market rose by 1.31% at 10:27 UTC this Wednesday as the current investment momentum sparked a stock market rally that spread to U.S. markets.The New York Stock Exchange also rose by 1.79 at 22:27 UTC.

Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1 – Emergent Biosolutions, Inc.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs).

Emergent Biosolutions, Inc. sales growth this year is anticipated to be 38.3% and 22.4% for next year.

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 1.33B for the twelve trailing months.

Emergent Biosolutions, Inc.’s sales growth for the next quarter is 104.4%. The company’s growth estimates for the current quarter and the next are 80.3% and 18200%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.57.

Emergent Biosolutions, Inc.’s stock is valued at $79.67 at 05:45 EST, way below its 52-week high of $137.61 and way higher than its 52-week low of $46.37.

Emergent Biosolutions, Inc.’s value is way below its 50-day moving average of $94.76 and way under its 200-day moving average of $96.56.

2 – Meritage Homes Corporation

Meritage Homes Corporation designs and builds single-family homes in the United States. The company operates through two segments, Homebuilding and Financial Services.

Meritage Homes Corporation sales growth this year is anticipated to be 20.4% and 22.7% for next year.

Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 4.23B for the twelve trailing months.

Meritage Homes Corporation’s sales growth for the next quarter is 27%. The company’s growth estimates for the ongoing quarter and the next are 20.9% and 46.4%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.39.

Meritage Homes Corporation’s stock is valued at $90.28 at 05:45 EST, way under its 52-week high of $117.06 and way higher than its 52-week low of $25.24.

Meritage Homes Corporation’s worth is under its 50-day moving average of $98.59 and above its 200-day moving average of $89.84.

3 – AMD

Advanced Micro Devices, Inc. operates as a semiconductor company worldwide.

AMD sales growth this year is anticipated to be 41.6% and 25.3% for next year.

Year-on-year quarterly revenue growth grew by 55.5%, now sitting on 8.65B for the twelve trailing months.

AMD’s sales growth for the next quarter is 47.6%. The company’s growth estimates for the ongoing quarter and the next are 43.8% and 94.4%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.09.

AMD’s stock is valued at $85.07 at 05:45 EST, under its 52-week high of $94.28 and way above its 52-week low of $36.75.

AMD’s value is above its 50-day moving average of $82.06 and way above its 200-day moving average of $70.94.

4 – Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corporation provides a secondary market for various loans made to borrowers in the United States.

Federal Agricultural Mortgage Corporation sales growth this year is expected to be 10.7% and 4.8% for next year.

Year-on-year quarterly revenue growth grew by 28.9%, now sitting on 190.38M for the twelve trailing months.

Federal Agricultural Mortgage Corporation’s sales growth for the next quarter is 13.3%. The company’s growth estimates for the present quarter and the next are 0.9% and 23.5%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.67.

Federal Agricultural Mortgage Corporation’s stock is valued at $67.66 at 05:45 EST, way under its 52-week high of $87.00 and way higher than its 52-week low of $40.05.

Federal Agricultural Mortgage Corporation’s value is higher than its 50-day moving average of $67.53 and above its 200-day moving average of $65.34.

5 – Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

Danaher Corporation sales growth this year is expected to be 22.6% and 15.6% for next year.

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 20.39B for the twelve trailing months.

Danaher Corporation’s sales growth for the next quarter is 34.1%. The company’s growth estimates for the present quarter and the next are 43% and 52.4%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.99.

Danaher Corporation’s stock is valued at $219.73 at 05:45 EST, way below its 52-week high of $248.32 and way higher than its 52-week low of $119.60.

Danaher Corporation’s value is below its 50-day moving average of $229.60 and way above its 200-day moving average of $198.99.

6 – Grifols, S.A.

Grifols, S.A. sales growth this year is expected to be 11.8% and 2.9% for next year.

Year-on-year quarterly revenue growth grew by 3%, now sitting on N/A for the twelve trailing months.

Grifols, S.A.’s sales growth for the next quarter is 10.7%. The company’s growth estimates for the present quarter and the next are 3.2% and 29.2%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.09.

Grifols, S.A.’s stock is valued at $19.03 at 05:45 EST, way below its 52-week high of $25.73 and way above its 52-week low of $13.40.

Grifols, S.A.’s worth is higher than its 50-day moving average of $18.17 and higher than its 200-day moving average of $18.39.

7 – MorphoSys AG

MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.

MorphoSys AG sales growth this year is expected to be 382.2% and -35.1% for next year.

Year-on-year quarterly revenue growth grew by 76.4%, now sitting on N/A for the twelve trailing months.

MorphoSys AG’s sales growth for the next quarter is 169.8%. The company’s growth estimates for the ongoing quarter and the next are 0% and 63%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31.

MorphoSys AG’s stock is valued at $26.68 at 05:45 EST, way under its 52-week high of $37.96 and way higher than its 52-week low of $18.21.

MorphoSys AG’s value is below its 50-day moving average of $26.97 and way under its 200-day moving average of $30.70.

8 – Afya Limited

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Afya Limited sales growth this year is expected to be 59.1% and 35.6% for next year.

Year-on-year quarterly revenue growth grew by 53.6%, now sitting on N/A for the twelve trailing months.

Afya Limited’s sales growth for the next quarter is 49%. The company’s growth estimates for the present quarter and the next are -71.8% and 19%, respectively. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.45.

Afya Limited’s stock is valued at $26.96 at 05:45 EST, way under its 52-week high of $34.87 and way above its 52-week low of $13.98.

Afya Limited’s worth is higher than its 50-day moving average of $26.20 and way higher than its 200-day moving average of $24.19.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here